ANTIBODIES

Contributor Information
- Institute University of Illinois Chicago
Tool Details
- Tool name: Anti-LPP3 [046]
- Alternate names: PLPP3, Dri42, PAP2B, VCIP, PPAP2B or phospholipid phosphatase 3
- Tool type: Antibodies
- Tool sub-type: Primary antibody
- Class: Monoclonal
- Conjugate: Unconjugated
- Reactivity: Human ; Mouse
- Host: Mouse
- Application: FACS ; IP ; WB
- Description: An antibody against the extracellular domain of LPP3 inhibits cell-cell interactions and angiogenesis in vitro. In addition, LPP3 not only catalyzes the dephosphorylation of the bioactive lipid sphingosine-1-phosphate (S1P) to generate sphingosine but also may regulate embryonic development and angiogenesis via the Wnt pathway. LPP3 also has the ability to potentiate tumor growth by amplifying B-catenin and CYCLIN-D1 activities. Thus, LPP3 is a potential target for inhibiting the growth of glioblastoma, an aggressive type of brain tumor, and other LPP3-expressing tumors. This may serve as a link in the acquisition of proliferative, invasive, and metastatic phenotypes.
- Immunogen: A modified synthetic peptide (YRCRGDDSKVQEARKSFFc-KLH) corresponding to 179-196 of human LPP3 conjugated to keyhole limpet hemocyanin
- Research area: Cell biology; Cancer; Cell signaling and signal transduction
- For Research Use Only
Target Details
- Target: Lipid Phosphate Phosphohydrolase 3
- Target background: An antibody against the extracellular domain of LPP3 inhibits cell-cell interactions and angiogenesis in vitro. In addition, LPP3 not only catalyzes the dephosphorylation of the bioactive lipid sphingosine-1-phosphate (S1P) to generate sphingosine but also may regulate embryonic development and angiogenesis via the Wnt pathway. LPP3 also has the ability to potentiate tumor growth by amplifying B-catenin and CYCLIN-D1 activities. Thus, LPP3 is a potential target for inhibiting the growth of glioblastoma, an aggressive type of brain tumor, and other LPP3-expressing tumors. This may serve as a link in the acquisition of proliferative, invasive, and metastatic phenotypes.
Application Details
- Application: FACS ; IP ; WB
Handling
- Format: Liquid
- Shipping conditions: Shipping at 4ðC
References
- • Humtsoe et al. 2010. Mol Cell Biol. 30(7):1593-606. PMID: 20123964.